Clinical blood tests for fetal sex are wrong roughly 1 to 2% of the time when performed under standard conditions, meaning they’re highly accurate but not perfect. The specific error rate depends on the type of test, how early in pregnancy it’s drawn, and whether certain biological factors are present that can confuse the results.
Clinical NIPT vs. At-Home Kits
The most common blood test for fetal sex is non-invasive prenatal testing (NIPT), which analyzes fragments of placental DNA circulating in the mother’s blood. When performed in a certified lab from a medical blood draw, NIPT identifies fetal sex with roughly 95% or higher accuracy. The American College of Obstetricians and Gynecologists describes cell-free DNA testing as the most sensitive and specific screening test for chromosomal conditions, though it emphasizes that it is a screening tool, not a diagnostic one.
At-home consumer tests like SneakPeek work on a similar principle but are far less reliable. Independent assessments put their real-world accuracy somewhere in the range of 50 to 70%. The main problem is contamination. These tests detect tiny traces of Y-chromosome DNA to determine if the fetus is male, and even brief contact with male family members, surfaces, or household items can introduce enough male DNA to produce a false “boy” result. Lab-controlled environments eliminate this risk almost entirely, which is why clinical draws perform so much better.
Why Results Sometimes Come Back Wrong
Several biological factors can trip up even a properly run clinical test. The most common causes of false results involve the mother’s own genetics, the placenta, or a pregnancy that started as twins.
In a large study of over 24,000 pregnancies, researchers found that about 0.69% were flagged for sex chromosome abnormalities, but a significant portion of those turned out to be false positives. The main culprits were maternal sex chromosome variations (where the mother herself carries an extra or altered X chromosome, sometimes without knowing it), copy number variations in the mother’s DNA, and confined placental mosaicism, a condition where the placenta has a different genetic makeup than the fetus. In one documented case, placental tissue showed abnormal chromosomes in 12 to 92% of cells, while the actual fetus was genetically normal.
Vanishing twin syndrome is another well-documented cause of incorrect sex results. When a twin pregnancy naturally reduces to a single fetus early on, the demised twin’s placenta can continue releasing DNA into the mother’s bloodstream for eight weeks or longer after the loss. If the surviving baby is female but the vanishing twin was male, the test picks up Y-chromosome DNA and reports a boy. Standard counting-based NIPT methods cannot distinguish between DNA from the viable fetus and DNA from a demised twin, so this error is essentially invisible to the test.
How Timing Affects Accuracy
NIPT is typically performed after 10 weeks of pregnancy because, before that point, the concentration of fetal DNA in the mother’s blood is often too low for reliable results. This concentration, called the fetal fraction, is the percentage of free-floating DNA in the mother’s blood that actually comes from the placenta rather than from her own cells.
Research on twin pregnancies found that sex determination is accurate for nearly all pregnancies when the fetal fraction exceeds 10%, but accuracy drops to around 50% when the fraction is between 6 and 10%. The theoretical minimum fetal fraction needed to distinguish sex at all is less than 3%, but real-world variation in the data means results at that level are unreliable. Most labs require a minimum fetal fraction (commonly around 3 to 4%) to issue any result, and will return a “no call” or test failure rather than guess.
A small study testing pregnancies between 6 and 9 weeks found that sex was correctly identified in all 28 successful cases, but one sample at just over 7 weeks failed entirely and produced no result. Testing before 10 weeks is more likely to produce a test failure than an outright wrong answer, but the risk of insufficient fetal DNA is real. If your blood is drawn too early and the fetal fraction is borderline, you may get a result that looks definitive but rests on thin data.
IVF Pregnancies and Genetic Testing
If you conceived through IVF with preimplantation genetic testing, you may already have a sex determination from the embryo stage. That result is generally reliable, but ACOG notes that false positives and false negatives are possible with any form of preimplantation testing. The embryo biopsy samples only a few cells from the outer layer of the embryo, and those cells don’t always reflect the genetics of the inner cell mass that becomes the baby. Mosaicism, where different cells in the same embryo carry different chromosomes, is an emerging issue that can occasionally cause a mismatch between what the biopsy shows and what the fetus actually is.
For IVF pregnancies, standard prenatal screening including NIPT is still recommended regardless of preimplantation results. If your NIPT sex result conflicts with what was reported at the embryo stage, it warrants a conversation with your provider about confirmatory testing.
Which Errors Are More Common
False male results (being told “boy” when the baby is actually a girl) are more common than the reverse, because the test is looking for the presence or absence of Y-chromosome DNA. Any contamination or extra DNA source that introduces Y-chromosome material, whether from a vanishing twin, a lab error, or male DNA on an at-home test kit, will push the result toward male. A false female result is less common because it would require the test to completely miss Y-chromosome DNA that is actually there, which typically only happens when the fetal fraction is very low or the sample quality is poor.
For screening of sex chromosome conditions specifically (like Turner syndrome or Klinefelter syndrome), the accuracy picture is more nuanced. A meta-analysis found that detection rates for Turner syndrome ranged from about 84 to 94% depending on the sequencing method used, with specificity above 99%. Rarer conditions involving extra sex chromosomes had detection rates of 76% or higher, though the data is based on small numbers of affected pregnancies.
What a Wrong Result Actually Looks Like
Most people discover a sex discrepancy at their anatomy ultrasound, typically performed around 18 to 20 weeks. If the ultrasound shows anatomy that conflicts with the blood test, the ultrasound is generally considered more reliable for sex determination at that stage because it’s based on direct visualization rather than DNA fragments. In rare cases, the discrepancy isn’t caught until delivery.
If you have reason to doubt your result, such as a known vanishing twin, a very early blood draw, or an at-home test, a follow-up ultrasound is the simplest way to confirm. For medical decisions that depend on fetal sex (such as sex-linked genetic conditions), diagnostic procedures like amniocentesis provide a definitive answer from the fetus’s own cells.